Clinical Trial: 2 doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting


	Home	\|	Search	\|	Browse	\|	Resources	\|	Help	\|	What's New	\|	About

2 doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting

This study is currently recruiting patients.

Sponsored by:	Merck
Information provided by:	Merck

Purpose

The purpose of this study is to assess the safety and efficacy of 2 doses of an approved drug for a new indication in the prevention of postoperative nausea and vomiting in patients receiving general anesthesia for open abdominal surgery requiring overnight hospital stay.

Condition	Treatment or Intervention	Phase
Postoperative Nausea and Vomiting		Phase II Phase III

MedlinePlus related topics: Nausea and Vomiting

Study Type: Interventional
Study Design: Prevention, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study

Official Title: A Randomized, Double-Blind, Active Comparator-Controlled, Parallel-Group Study, to Examine the Safety, Tolerability, and Efficacy of 2 doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting

Eligibility

Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both

Criteria

Inclusion Criteria:

Patient is at least 18 years of age.
Patient is scheduled to undergo open abdominal surgery requiring overnight hospital stay (24-hour hospital stay after end of surgery).
Patient is scheduled to receive general anesthesia.
Patient is scheduled to receive postoperative opioids.

Location and Contact Information

Toll Free Number 1-888-577-8839

Pennsylvania
Call for Information, Horsham, Pennsylvania, 19044, United States; Recruiting

More Information

Study ID Numbers: 2004_014
Record last reviewed: October 2004
Record first received: August 25, 2004
ClinicalTrials.gov Identifier: NCT00090246
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2004-10-29

U.S. National Library of Medicine, Contact NLM Customer Service

National Institutes of Health, Department of Health & Human Services